The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007
Prevalence and risk factors of sepsis in very old patients with CAP Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019
Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006
Influence of concomitant diseases on death rate of patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 202s Year: 2002
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004
Incidence, risk factors and outcomes of nonresolving pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Impact of age and comorbidity on presentation, aetiology and outcome in patients with community-acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008
The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006
Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Presence of aspiration pneumonia is independently associated with mortality, after adjusting for age, disease severity, and comorbities Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011
Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013
The incidence and risk factors of ventilator associated pneumonia on the mortality in patients with traumatic brain injury Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Risk factors contributing to mortality in patients with COPD developing acute respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
Treatment failure of community-acquired pneumonia: risk factors and consequences Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017
Telithromycin is effective in the treatment of patients with acute exacerbations of chronic bronchitis and risk factors for morbidity Source: Eur Respir J 2002; 20: Suppl. 38, 545s Year: 2002